Genistein induces radioprotection by hematopoietic stem cell quiescence

International Journal of Radiation Biology

Volumn 84, Issue 9, 2008, Pages 713-726

  Davis, Thomas A ^a   Mungunsukh, Ognoon ^b   Zins, Stephen ^a   Day, Regina M ^b   Landauer, Michael R ^b  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Hematopoietic reconstitution; Hematopoietic stem cells; Irradiation myeloablation; Radioprotectants; Stem cell cycling

Indexed keywords

7 AMINODACTINOMYCIN; ATAXIN 1; GENISTEIN; KI 67 ANTIGEN; LEUCOCYTE CARBOXYL TERMINAL SRC KINASE; LIN PROTEIN; MACROGOL 400; STEM CELL ANTIGEN 1; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TOXICITY; C57BL 6 MOUSE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HEMATOPOIETIC STEM CELL; LETHAL DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; STAINING; WHOLE BODY RADIATION;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW; CELL AGING; CELL CYCLE; CELL LINEAGE; DNA DAMAGE; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENISTEIN; HEMATOPOIETIC STEM CELLS; INJECTIONS, SUBCUTANEOUS; MICE; RADIATION DOSAGE; RADIATION-PROTECTIVE AGENTS;

MUS;

EID: 52949137022     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000802317778     Document Type: Article

References (49)

1. Arai F, Suda T. 2007. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Annals of the New York Academy of Sciences 1106:41-53.
2. Banker DE, Groudine M, Willman CL, Norwood T, Appelbaum FR. 1998. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents. Leukemia Research 22:221-239.
3. Bertoncello I, Kriegler AB, Woodcock DM, Williams B, Barber L, Nilsson SK. 1995. Haematopoietic radioprotection by Cremophor EL: A polyethoxylated castor oil. International Journal of Radiation Biology 67:57-64.
4. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501.
5. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-846.
6. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804-1808.
7. Cheshier SH, Morrison SJ, Liao X, Weissman IL. 1999. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proceedings of the National Academy of Sciences USA 96:3120-3125.
8. Davis TA, Clarke TK, Mog SR, Landauer MR. 2007. Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival. International Journal of Radiation Biology 83:141-151.
9. Day RM, Kupper-Barshishat M, Mog SR, McCart EA, Prasanna PGS, Davis TA, Landauer MR. 2008. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. Journal of Radiation Research 49:361-372.
10. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
11. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
12. Harrison DE, Lerner CP. 1991. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood 78:1237-1240.
13. Hermann RM, Fest J, Christiansen H, Hille A, Rave-Frank M, Nitsche M, Grundker C, Viereck V, Jarry H, Schmidberger H. 2007. Radiosensitization dependent on p53 function in bronchial carcinoma cells by the isoflavone genistein and estradiol in vitro. Strahlentherapie und Onkologie 183:195-202.
14. Hillman GG, Forman JD, Kucuk O, Yudelev M, Maughan RL, Rubio J, Layer A, Tekyi-Mensah S, Abrams J, Sarkar FH. 2001. Genistein potentiates the radiation effect on prostate carcinoma cells. Clinical Cancer Research 7:382-390.
15. Hillman GG, Wang Y, Che M, Raffoul JJ, Yudelev M, Kucuk O, Sarkar FH. 2007. Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model. BMC Cancer 7:4.
16. Hodgson GS, Bradley TR, Radley JM. 1982. The organization of hemopoietic tissue as inferred from the effects of 5-fluorouracil. Experimental Hematology 10:26-35.
17. Jetmore A, Plett PA, Tong X, Wolber FM, Breese R, Abonour R, Orschell-Traycoff CM, Srour EF. 2002. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood 99:1585-1593.
18. Landauer MR, Castro CA, Benson KA, Hogan JB, Weiss JF. 2001. Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327. Journal of Applied Toxicology 21:25-31.
19. Landauer MR, Srinivasan V, Seed TM. 2003. Genistein treatment protects mice from ionizing radiation injury. Journal of Applied Toxicology 23:379-385.
20. Li Z, Li J, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J. 2008. Genistein induces G(2)/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biology and Toxicology, in press.
21. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A. 1993. Genistein arrests cell cycle progression at G2-M. Cancer Research 53:1328-1331.
22. Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld JL, Deeg HJ. 1995. Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy. International Journal of Radiation Oncology, Biology, Physics 31:1319-1339.
23. McPherson C. 1963. Reduction of Psuedomonas aeruginosa and coliform bacteria in mouse drinking water following treatment with hyrdochloric acid and chlorine. Laboratory Animal Care 13:737-744.
24. Mohammad RM, Al-Katib A, Aboukameel A, Doerge DR, Sarkar F, Kucuk O. 2003. Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. Molecular Cancer Therapeutics 2:1361-1368.
25. Moos WS, LeVan H, Mason HC. 1967. Radioprotective effects of dimethyl sulfoxide vapor on mice. Experientia 23:923.
26. Morrison SJ, Weissman IL. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1:661-673.
27. Orschell-Traycoff CM, Hiatt K, Dagher RN, Rice S, Yoder MC, Srour EF. 2000. Homing and engraftment potential of Sca-1(+)Lin(-) cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 96:1380-1387.
28. Papazisis KT, Zambouli D, Kimoundri OT, Papadakis ES, Vala V, Geromichalos GD, Voyatzi S, Markala D, Destouni E, Boutis L, Kortsaris AH. 2000. Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation. Cancer Letters 160:107-113.
29. Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. 2005. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. The Journal of Experimental Medicine 202:1599-1611.
30. Pawlik TM, Keyomarsi K. 2004. Role of cell cycle in mediating sensitivity to radiotherapy. Journal of Radiation Oncology, Biology, Physics 59:928-942.
31. Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG. 2006. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6:107.
32. Rosen EM, Fan S, Rockwell S, Goldberg ID. 1999. The molecular and cellular basis of radiosensitivity: Implications for understanding how normal tissues and tumors respond to therapeutic radiation. Cancer Investigation 17:56-72.
33. Shaeffer J, Schellenberg KA. 1984. Polyethylene glycol as a protector against head and neck irradiation. Journal of Radiation Oncology, Biology, Physics 10:2329-2333.
34. Srour EF, Jetmore A, Wolber FM, Plett PA, Abonour R, Yoder MC, Orschell-Traycoff CM. 2001. Homing, cell cycle kinetics and fate of transplanted hematopoietic stem cells. Leukemia 15:1681-1684.
35. Steinman RA. 2002. Cell cycle regulators and hematopoiesis. Oncogene 21:3403-3413.
36. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G. 1998. The alternative product from the human Cdkn2a locus, p14(Arf), participates in a regulatory feedback loop with p53 and Mdm2. EMBO Journal 17:5001-5014.
37. Tamulevicius P, Wang M, Iliakis G. 2007. Homology-directed repair is required for the development of radioresistance during S phase: Interplay between double-strand break repair and checkpoint response. Radiation Research 167:1-11.
38. Tanaka T, Halicka HD, Traganos F, Darzynkiewicz Z. 2006. Phosphorylation of histone H2AX on ser 139 and activation of ATM during oxidative burst in phorbol ester-treated human leukocytes. Cell Cycle 5:2671-2675.
39. Tanaka T, Kajstura M, Halicka HD, Traganos F, Darzynkiewicz Z. 2007. Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes. Cell Proliferation 40:1-13.
40. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. 1992. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic Molt-4 and HL-60 cells. Cancer Research 52:6200-6208.
41. Valachovicova T, Slivova V, Sliva D. 2004. Cellular and physiological effects of soy flavonoids. Mini Reviews in Medicinal Chemistry 4:881-887.
42. Walkley CR, Fero ML, Chien WM, Purton LE, McArthur GA. 2005. Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Nature Cell Biology 7:172-178.
43. Wang Y, Schulte BA, Zhou D. 2006. Hematopoietic stem cell senescence and long-term bone marrow injury. Cell Cycle 5:35-38.
44. Wlodarski P, Wasik M, Ratajczak MZ, Sevignani C, Hoser G, Kawiak J, Gewirtz AM, Calabretta B, Skorski T. 1998. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood 91:2998-3006.
45. Yang L, Bryder D, Adolfsson J, Nygren J, Mansson R, Sigvardsson M, Jacobsen SE. 2005. Identification of Lin(-) Sca1(+)kit(+)CD34(+)Flt3(-) short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 105:2717-2723.
46. Yashar CM, Spanos WJ, Taylor DD, Gercel-Taylor C. 2005. Potentiation of the radiation effect with genistein in cervical cancer cells. Gynecologic Oncology 99:199-205.
47. Yellayi S, Naaz A, Szewczykowski MA, Sato T, Woods JA, Chang J, Segre M, Allred CD, Helferich WG, Cooke PS. 2002. The phytoestrogen genistein induces thymic and immune changes: A human health concern? Proceedings of the National Academy of Sciences USA 99:7616-7621.
48. Yousefi S, Green DR, Blaser K, Simon HU. 1994. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proceedings of the National Academy of Sciences USA 91:10868-10872.
49. Zinberg N, Kohn A. 1971. Dimethyl sulfoxide protection of bone marrow cells of mice against X-ray damage. Israeli Journal of Medical Science 7:713-718.